Abstract:Stroke is the second highest disease causing burden on the global economy and one of the leading causes of non-traumatic disability [ [1] Murray C.J. Lopez A.D. Measuring the global burden of disease[J]. N Engl J Med. 2013; 369: 448-457https://doi.org/10.1056/NEJMra1201534 Crossref PubMed Scopus (1151) Google Scholar ]. As many as 30–40% of ischemic stroke cases have no identified medical cause, known as cryptogenic stroke (CS) [ [2] Hart R.G. Diener H.C. Coutts S.B. et al. Embolic strokes of undetermined source: the case for a new clinical construct[J]. Lancet Neurol. 2014; 13: 429-438https://doi.org/10.1016/S1474-4422(13)70310-7 Abstract Full Text Full Text PDF PubMed Scopus (916) Google Scholar ]. Within the last century, the incidence of patent foramen ovale (PFO) in patients with CS is as high as 50–60%, which is significantly higher than 20–30% in the normal population [ [3] Hara H. Virmani R. Ladich E. et al. Patent foramen ovale: current pathology, pathophysiology, and clinical status[J]. J Am Coll Cardiol. 2005; 46: 1768-1776https://doi.org/10.1016/j.jacc.2005.08.038 Crossref PubMed Scopus (230) Google Scholar ]. In the past two decades, to explore the effective treatment of patients with CS and PFO, several related experiments have been conducted in the academic community. After contradictory views and negative results, it was finally confirmed that closure therapy can significantly reduce the risk of stroke recurrence [ 4 Mas J.L. Derumeaux G. Guillon B. et al. Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke[J]. N Engl J Med. 2017; 377: 1011-1021https://doi.org/10.1056/NEJMoa1705915 Crossref PubMed Scopus (565) Google Scholar , 5 Saver J.L. Carroll J.D. Thaler D.E. et al. Long-Term outcomes of patent foramen ovale closure or medical therapy after stroke[j]. N Engl J Med. 2017; 377: 1022-1032https://doi.org/10.1056/NEJMoa1610057 Crossref PubMed Scopus (531) Google Scholar , 6 Søndergaard L. Kasner S.E. Rhodes J.F. et al. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke[j]. New England Journal of Medicine. 2017; 377: 1033-1042https://doi.org/10.1056/NEJMoa1707404 Crossref PubMed Scopus (554) Google Scholar ]. However, literature on the Asian population with a high incidence of stroke, particularly on biomarkers for risk factors for stroke recurrence, is currently lacking.

Research Progress of Paroxysmal Atrial Fibrillation and Cryptogenic Stroke

Potential Role of 2-Phase Cardiac CT in Patients with Embolic Stroke of Undetermined Source

A Comprehensive Review of Cryptogenic Stroke and Atrial Fibrillation: Real-World Insights Into the Role of Insertable Cardiac Monitors

A Cross Sectional Study of Atrial Fibrillation Prevalence and Associated Cardiac Arrhythmias in Stroke Patients: Insights from Commercial Data Archives

Monitoring for atrial fibrillation prior to patent foramen ovale closure after cryptogenic stroke

Research progress in Patent foramen ovale and cryptogenic stroke

Comparison of Stroke Recurrence Between Antiplatelet and Closure Therapy in Cryptogenic Stroke Patients with Patent Foramen Ovale and Its Influencing Factors

Clinical and Infarction Patterns of PFO‐related Cryptogenic Strokes and a Prediction Model

Performance of Different Risk Scores for the Detection of Atrial Fibrillation Among Patients With Cryptogenic Stroke

Insertable cardiac monitors for detection of atrial fibrillation after cryptogenic stroke: a meta-analysis

The Usefulness of Outpatient Cardiac Telemetry in Patients with Cryptogenic Stroke

Closing Patent Foramen Ovale in Cryptogenic Stroke: the Underscored Importance of Other Interatrial Shunt Variants

Research on atrial fibrillation mechanisms and prediction of therapeutic prospects: focus on the autonomic nervous system upstream pathways

Ignored Role of Paroxysmal Atrial Fibrillation in the Pathophysiology of Cryptogenic Stroke in Patients with Patent Foramen Ovale and Atrial Septal Aneurysm

Newly Detected Atrial Fibrillation after Acute Stroke: A Narrative Review of Causes and Implications

Advances in the study of new anticoagulant drugs for atrial ifbrillation

Higher Frequency of Premature Atrial Contractions Correlates With Atrial Fibrillation Detection after Cryptogenic Stroke

ESC Working Group on e-Cardiology Position Paper: accuracy and reliability of electrocardiogram monitoring in the detection of atrial fibrillation in cryptogenic stroke patients

PO-661-03 USE OF A DEEP LEARNING ALGORITHM TO PREDICT PAROXYSMAL ATRIAL FIBRILLATION BASED ON PRINTED ELECTROCARDIOGRAPHIC RECORDS ACQUIRED DURING SINUS RHYTHM

Atrial Cardiomyopathy: An Emerging Cause of the Embolic Stroke of Undetermined Source

The research progressabout anticoagulant therapy of atrial fibrillation